![Salesforce stock falls amid skepticism over new COFO role](https://i-invdn-com.investing.com/news/LYNXNPEC1O0N5_S.jpg)
Please try another search
Date | Price | Open | High | Low | Change % |
---|---|---|---|---|---|
Feb 05, 2025 | 84.460 | 84.460 | 84.460 | 84.460 | 0.27% |
Feb 04, 2025 | 84.230 | 84.230 | 84.230 | 84.230 | -0.02% |
Feb 03, 2025 | 84.250 | 84.250 | 84.250 | 84.250 | 0.59% |
Jan 31, 2025 | 83.760 | 83.760 | 83.760 | 83.760 | 0.43% |
Jan 30, 2025 | 83.400 | 83.400 | 83.400 | 83.400 | 0.46% |
Jan 29, 2025 | 83.020 | 83.020 | 83.020 | 83.020 | -0.10% |
Jan 28, 2025 | 83.100 | 83.100 | 83.100 | 83.100 | -0.16% |
Jan 27, 2025 | 83.230 | 83.230 | 83.230 | 83.230 | 0.24% |
Jan 24, 2025 | 83.030 | 83.030 | 83.030 | 83.030 | -0.10% |
Jan 23, 2025 | 83.110 | 83.110 | 83.110 | 83.110 | -0.22% |
Jan 22, 2025 | 83.290 | 83.290 | 83.290 | 83.290 | -0.07% |
Jan 21, 2025 | 83.350 | 83.350 | 83.350 | 83.350 | 0.17% |
Jan 20, 2025 | 83.210 | 83.210 | 83.210 | 83.210 | 0.11% |
Jan 17, 2025 | 83.120 | 83.120 | 83.120 | 83.120 | 0.13% |
Jan 16, 2025 | 83.010 | 83.010 | 83.010 | 83.010 | 0.18% |
Jan 15, 2025 | 82.860 | 82.860 | 82.860 | 82.860 | 0.79% |
Jan 14, 2025 | 82.210 | 82.210 | 82.210 | 82.210 | -0.19% |
Jan 13, 2025 | 82.370 | 82.370 | 82.370 | 82.370 | -0.24% |
Jan 10, 2025 | 82.570 | 82.570 | 82.570 | 82.570 | -0.27% |
Jan 09, 2025 | 82.790 | 82.790 | 82.790 | 82.790 | -0.22% |
Jan 08, 2025 | 82.970 | 82.970 | 82.970 | 82.970 | -0.30% |
Jan 07, 2025 | 83.220 | 83.220 | 83.220 | 83.220 | -0.26% |
Jan 06, 2025 | 83.440 | 83.440 | 83.440 | 83.440 | -0.01% |
Highest: 84.460 | Lowest: 82.210 | Difference: 2.250 | Average: 83.217 | Change %: 1.210 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review